Filing Details
- Accession Number:
- 0001181431-12-050719
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-17 13:23:44
- Reporting Period:
- 2012-09-13
- Filing Date:
- 2012-09-17
- Accepted Time:
- 2012-09-17 13:23:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1124608 | Response Genetics Inc | RGDX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1118292 | Swiftcurrent Partners, L.p. | 90 Park Avenue 40Th Floor New York NY 10016 | No | No | Yes | No | |
1124973 | Swiftcurrent Offshore, Ltd. | 90 Park Avenue 40Th Floor New York NY 10016 | No | No | Yes | No | |
1166309 | Bridger Management, Llc | 90 Park Avenue 40Th Floor New York NY 10016 | No | No | Yes | No | |
1258394 | Roberto Mignone | 90 Park Avenue 40Th Floor New York NY 10016 | No | No | Yes | No | |
1410684 | Bridger Capital Llc | 90 Park Avenue 40Th Floor New York NY 10016 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.01 Per Share | Acquisiton | 2012-09-13 | 3,000,000 | $1.10 | 6,000,000 | No | 4 | P | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnotes |
Footnotes
- The shares of the Issuer's Common Stock, par value $.01 per share (the "Shares") reported herein as indirectly beneficially owned by Bridger Management, LLC ("Bridger") are directly beneficially owned by Swiftcurrent Partners, L.P. and Swiftcurrent Offshore, Ltd., over which Bridger shares investment control ("the Funds"). For such reason, Bridger may be deemed to beneficially own such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16").
- The Shares reported herein as indirectly beneficially owned by Roberto Mignone ("Mr. Mignone") are directly beneficially owned by Swiftcurrent Partners, L.P. and Swiftcurrent Offshore, Ltd., over which Mr. Mignone shares investment control. For such reason, Mr. Mignone may be deemed to beneficially own such securities for purposes of Section 16.
- The Shares reported herein as indirectly beneficially owned by Bridger Capital, LLC ("Bridger Capital") are directly beneficially owned by Swiftcurrent Partners, L.P. of which Bridger Capital is the General Partner. For such reason, Bridger Capital may be deemed to beneficially own such securities for purposes of Section 16.
- Each reporting person and entity named herein disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein and this report shall not be deemed an admission that the reporting person or any entity named herein is the beneficial owner of the securities for purposes of Section 16, or for any other purpose.
- Bridger, Bridger Capital and the Funds are under common control and may be deemed to be, but do not admit to being, a group for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934.